title: [Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension].
abstract: To improve the management of hypertension in the French population, the French Society of Hypertension has decided to update the national guidelines with the following characteristics: usefulness for practice, synthetic form, good readability, comprehensive writing for non-doctors, emphasizing the role of patient education in the management of hypertension, wide dissemination to health professionals and the population of hypertensive subjects, impact assessment among health professionals and the public health goals. These guidelines include the following 15 recommendations, divided in three chapters, according to the timing of the medical management.
  1. Confirm the diagnosis, with blood pressure measurements outside the doctor's office. 2. Implement lifestyle measures. 3. Conduct an initial assessment. 4. Arrange a dedicated information and hypertension announcement consultation. INITIAL TREATMENT PLAN (FIRST 6 MONTHS): 5.
  
  
  OBJECTIVE
  control of blood pressure in the first 6 months (SBP: 130-139 and DBP<90 mmHg). 6. Favour the five classes of antihypertensive agents that have demonstrated prevention of cardiovascular complications in hypertensive patients. 7. Individualized choice of the first antihypertensive treatment, taking into account persistence. 8. Promote the use of (fixed) combination therapy in case of failure of monotherapy. 9. Monitor safety.
  10. Uncontrolled hypertension at 6 months despite appropriate triple-drug treatment should require specialist's opinion after assessment of compliance and confirmation of ambulatory hypertension. 11. In case of controlled hypertension, visits every 3 to 6 months. 12. Track poor adherence to antihypertensive therapy. 13. Promote and teach how to practice home blood pressure measurement. 14. After 80 years, change goal BP (SBP<150 mmHg) without exceeding three antihypertensive drugs. 15. After cardiovascular complication, treatment adjustment with maintenance of same blood pressure goal. We hope that a vast dissemination of these simple guidelines will help to improve hypertension control in the French population from 50 to 70 %, an objective expected to be achieved in 2015 in France.
authors.affiliation: contact.sfhta@cardio-sfc.org
authors.forename: J
authors.initials: J
authors.lastname: Blacher
authors.forename: J-M
authors.initials: JM
authors.lastname: Halimi
authors.forename: O
authors.initials: O
authors.lastname: Hanon
authors.forename: J-J
authors.initials: JJ
authors.lastname: Mourad
authors.forename: A
authors.initials: A
authors.lastname: Pathak
authors.forename: B
authors.initials: B
authors.lastname: Schnebert
authors.forename: X
authors.initials: X
authors.lastname: Girerd
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D018660:Blood Pressure Monitoring, Ambulatory; D019468:Disease Management; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005602:France; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D055118:Medication Adherence; D010353:Patient Education as Topic; D057285:Precision Medicine; D040242:Risk Reduction Behavior
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations